Navigation Links
Vermillion Reports First Quarter 2012 Results
Date:5/15/2012

>

Investor Relations:
Liolios Group, Inc.
Ron Both
Tel 949-574-3860
info@liolios.com

 Vermillion, Inc.Consolidated Balance Sheets(Amounts in Thousands, Except Share and Par Value Amounts)(Unaudited)March 31,December 31,20122011AssetsCurrent assets:Cash and cash equivalents

$
9,850$
22,477Accounts receivable

11499Prepaid expenses and other current assets

367317Total current assets

20,33122,893Property and equipment, net

202216Other assets

82Total assets

$
20,541$
23,111Liabilities and Stockholders' EquityCurrent liabilities:Accounts payable

$
714$
,331Accrued liabilities

2,2552,592Short-term debt

7,0007,000Deferred revenue

735553Total current liabilities

10,70411,476Deferred revenue

1,1111,224Other liabilities

-52Total liabilities

11,81512,752Commitments and contingencies

 Stockholders' equity:Preferred stock, $0.001 par value, 5,000,000 shares authorized, none issued and outstanding at March 31, 2012  and December 31, 2011, respectively

--Common stock, $0.001 par value, 150,000,000 shares authorized; 14,921,913 and 14,900,831 shares issued and outstanding at March 31, 2012 and December 31, 2011, respectively

1515Additional paid-in capital

326,942326,796Accumulated deficit

(318,075)(316,299)Accumulated other comprehensive loss

(156)(153)Total stockholders' equity

8,72610,359Total liabilities and stockholders' equity

$
20,541$
23,111Vermillion, Inc.Consolidated Statements of Operations(Amounts in Thousands, Except Share and Per Share Amounts)(Unaudited)Three months ended March 31,20122011Revenue:Product

$
98$
317License

114114Total revenue

312431Cost of revenue:Product

3842Total cost of revenue

'/>"/>
SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vermillion Reports Fourth Quarter and Full Year 2011 Results
2. Vermillion Sharpens Focus and Streamlines Operations in 2012
3. Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease
4. Vermillion Reports Results for the Second Quarter 2011
5. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
6. Vermillion Announces Joining Russell Microcap® Index
7. Vermillion Announces Notice of Allowance for Alzheimer Patent
8. Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
9. Vermillion to Host Conference Call to Present Company Update and Review Financial Results for the First Quarter 2011
10. Stephens Initiates Coverage on Vermillion
11. Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CAMBRIDGE, Mass. , May 22, 2013  Moderna ... revolutionary new treatment modality to enable the in ... John Reynders will join Moderna ... Reynders is a proven leader in ... phases of drug development, from discovery to translation, clinical ...
(Date:5/21/2013)... May 21, 2013  The Lindsley F. Kimball Research Institute ... is a Grand Challenges Explorations winner, an initiative ... Dr. Sara Lustigman , Head of the ... and development research project, titled Innovative 3-D in ... are needed to screen drugs to help eliminate onchocerciasis (river ...
(Date:5/21/2013)... a new study led by George Washington University ... nucleation of ice in small droplets is strongly ... at the nanoscale. The formation of ice at ... question whose answer also has important implications for ... crystallization of ice from supercooled water is generally ...
(Date:5/21/2013)... Branchburg, NJ (PRWEB) May 21, 2013 ... enhancement industry, has appointed Dale Braddy to Southeastern USA ... proactively bolster its sales muscle in the Southeast. ... a food ingredient brokerage and supplier to food processors ... past 13 years in the food industry and has ...
Breaking Biology Technology:Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2
... Augments Senior Management Team with Recent Strategic Hires ... ... May 14 Triple-S,Management Corporation (NYSE: GTS ) today announced that ... for the Children,s Oncology Group and,the Dana Farber Acute Lymphoblastic Leukemia Consortium, ...
... Executive Chairman Set Sights on Expanding,Therapeutic Horizons of ... BOSTON, SAN DIEGO, SAN FRANCISCO and SEATTLE, May ... joined Fate Therapeutics as,president and CEO and executive ... internationally recognized stem cell scientists,clinicians and investors dedicated ...
... 14 Campbell Alliance,the leading management consulting firm ... that Gary Tyson, Senior Vice,President of the firm,s ... the global rollout of electronic data capture (EDC),systems ... will be,held on May 28-29, 2008, at the ...
Cached Biology Technology:Triple-S Management Corporation Appoints New Non-Executive Chairman to Board; Adds New Director 2Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team 2Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team 3Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team 4Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team 5Fate Therapeutics Taps Successful Biotech CEOs Paul Grayson and John Mendlein for Leadership Team 6Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe 2Campbell Alliance Clinical Development Practice to Present Session on Global EDC Rollout at Clinical Trials Congress, Europe 3
(Date:5/21/2013)... world,s largest scientific society, invites news media coverage ... 8-12, 2013, in Indianapolis, Ind. It will take ... area hotels. , With more than 7,100 presentations ... from astronomy to zoology ― the meeting will ... assortment of spot news and feature possibilities. The ...
(Date:5/21/2013)... the path of insulin action in cells in precise ... for understanding what goes wrong in diabetes. , ... David James from Sydney,s Garvan Institute of Medical Research, ... the prestigious journal Cell Metabolism . , First ... important role in the body because it helps us ...
(Date:5/20/2013)... Bacteria resistant to the antibiotic colistin are also ... human body, according to a study in ... American Society for Microbiology. Cross-resistance to colistin and ... the body against bacterial attack, could mean that ... saddled with a crippled immune response. Colistin is ...
Breaking Biology News(10 mins):Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... book designed for parents helps them better understand the ... fight them, while offering practical advice for preventing infections ... Your Kids: The Complete Guide to Protecting (without Overprotecting) ... Press, is the inside source on germ defense ...
... proteins have finally explained why computer models of proteins ... This work could have vast implications in bioengineering and ... between structure and function in these basic building blocks ... as the cover article of the Oct. 16 issue ...
... average price for all types of gasoline is holding ... at the pump might be short-lived as research from ... biggest hurdles to the wide-scale production of fuel cell-powered ... biomolecular engineering, led the research team in discovering a ...
Cached Biology News:Handbook helps parents deal with childhood infections 2Speed plays crucial role in breaking protein's H-bonds 2Speed plays crucial role in breaking protein's H-bonds 3Fuel cells gearing up to power auto industry 2Fuel cells gearing up to power auto industry 3
... microRNA expression profiling and built on ... on-chip synthesis platform. These microarrays are ... microRNA Expression Profiling Service. ... Microarray contains all known virus microRNAs ...
...
... is an excellent choice for supporting hydrocarbon processing. ... GC, this one-channel workhorse can double sample throughput ... one. You get all the capability and reliability ... instrument that has the same proven performance of ...
... GC-8A is Shimadzu's basic gas chromatograph model ... use, the GC-8A supports a single detector, ... injection port(s), and analog output. Isothermal or ... The GC-8A is only 17.3 inches (43.9 ...
Biology Products: